JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, D.
Right arrow Articles by Lim, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, D.
Right arrow Articles by Lim, J. H.
© 2002 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 21:391-401 • 0278-4297

Article

Assessment of Therapeutic Response in Hepatocellular Carcinoma Treated With Percutaneous Radio Frequency Ablation

Comparison of Multiphase Helical Computed Tomography and Power Doppler Ultrasonography With a Microbubble Contrast Agent

Dongil Choi, MD, Hyo K. Lim, MD, Seung Hoon Kim, MD, Won Jae Lee, MD, Hyun-Jung Jang, MD, Hana Kim, MD, Soon Jin Lee, MD and Jae Hoon Lim, MD

Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Address correspondence and reprint requests to Hyo K. Lim, MD, Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-Dong, Kangnam-Ku, Seoul 135-710, Korea.

Objective. To compare the results of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent in the assessment of the therapeutic response to radio frequency ablation in hepatocellular carcinoma. Methods. In 66 patients with 73 nodular hepatocellular carcinomas ranging from 1.0 to 4.0 cm (mean, 2.6 cm) in diameter, contrast-enhanced power Doppler ultrasonography was performed after intravenous bolus injection of a galactose-based microbubble contrast agent before and after radio frequency ablation. The results of the studies were compared with the findings of follow-up 3-phase helical computed tomography. All patients were regularly followed up with computed tomography for more than 1 year (range, 13–19 months). Results. In 8 (11%) of 73 hepatocellular carcinomas, immediate follow-up computed tomography obtained within 2 hours after radio frequency ablation showed focal enhancing portions within the treated lesions, suggesting residual non-necrotic tumors. All 8 of these tumors had intratumoral flow signals on contrast-enhanced power Doppler ultrasonography. The diagnostic agreement between computed tomography and contrast-enhanced power Doppler ultrasonography was achieved in 100%. Among the remaining 65 hepatocellular carcinomas with the absence of residual tumors at both immediate follow-up computed tomography and contrast-enhanced power Doppler ultrasonography, subsequent follow-up computed tomography showed local regrowth at the margins of 10 lesions (15%). Conclusions. The results of contrast-enhanced power Doppler ultrasonography closely correlated with those of immediate follow-up computed tomography for detecting residual tumors in hepatocellular carcinomas treated with radio frequency ablation. Both techniques, however, showed a limitation in detecting small or microscopic residual tumors and in predicting local regrowth in the treated lesions.

Abbreviations: CT, computed tomography • MR, magnetic resonance • PDUS, power Doppler ultrasonography

Key Words: liver neoplasms • radio frequency ablation • ultrasonography • contrast media • power Doppler studies • computed tomography




This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
D. Choi, H. K. Lim, M. J. Kim, S. J. Kim, S. H. Kim, W. J. Lee, J. H. Lim, S. W. Paik, B. C. Yoo, M. S. Choi, et al.
Liver Abscess After Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Frequency and Risk Factors
Am. J. Roentgenol., June 1, 2005; 184(6): 1860 - 1867.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
H.-X. Xu, L. Liu, M.-D. Lu, H.-P. Li, G.-J. Liu, and J.-P. Li
Three-dimensional Power Doppler Imaging in Depicting Vascularity in Hepatocellular Carcinoma
J. Ultrasound Med., November 1, 2003; 22(11): 1147 - 1154.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
D. Choi, H. K. Lim, W. J. Lee, S. H. Kim, Y. H. Kim, S. H. Kim, and J. H. Lim
Early Assessment of the Therapeutic Response to Radio Frequency Ablation for Hepatocellular Carcinoma: Utility of Gray Scale Harmonic Ultrasonography With a Microbubble Contrast Agent
J. Ultrasound Med., November 1, 2003; 22(11): 1163 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
J. H. Youk, J. M. Lee, and C. S. Kim
Therapeutic Response Evaluation of Malignant Hepatic Masses Treated by Interventional Procedures With Contrast-Enhanced Agent Detection Imaging
J. Ultrasound Med., September 1, 2003; 22(9): 911 - 920.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Institute of Ultrasound in Medicine.